Biopharmx Corp (NYSEAMERICAN:BPMX – Get Free Report) dropped 9.5% during trading on Monday . The company traded as low as $5.47 and last traded at $6.12. Approximately 336,508 shares changed hands during mid-day trading, a decline of 84% from the average daily volume of 2,150,348 shares. The stock had previously closed at $6.76.
Biopharmx Stock Performance
About Biopharmx
BioPharmX Corporation, a specialty pharmaceutical company, develops and commercializes novel prescription and over-the-counter (OTC) products that address dermatology and women's health markets. The company offers VI2OLET, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort, as well as alleviates the symptoms of fibrocystic breast condition (FBC).
Further Reading
- Five stocks we like better than Biopharmx
- Insider Trading – What You Need to Know
- 3 No-Brainer Stocks to Buy and Hold Long-Term
- Technology Stocks Explained: Here’s What to Know About Tech
- 3 Small Cap Stocks That Insiders Are Buying
- What Is WallStreetBets and What Stocks Are They Targeting?
- Analysts Forecast Big Upside for Western Digital—Don’t Miss Out
Receive News & Ratings for Biopharmx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biopharmx and related companies with MarketBeat.com's FREE daily email newsletter.
